Ultragenyx Pharmaceutical Inc. financial data

Symbol
RARE on Nasdaq
Industry
Pharmaceutical Preparations
Location
60 Leveroni Court, Novato, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 285 % -5.49%
Quick Ratio 14.2 % +22%
Debt-to-equity 398 % -38.5%
Return On Equity -187 % +46%
Return On Assets -37.6 % +19.1%
Operating Margin -102 % +29.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 92.3M shares +12.5%
Common Stock, Shares, Outstanding 92.3M shares +27.9%
Entity Public Float 3.1B USD -6.06%
Common Stock, Value, Issued 92K USD +27.8%
Weighted Average Number of Shares Outstanding, Basic 95.5M shares +33.3%
Weighted Average Number of Shares Outstanding, Diluted 95.5M shares +33.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 523M USD +27.4%
Research and Development Expense 671M USD +1.82%
Operating Income (Loss) -536M USD +9.62%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -561M USD +11.6%
Income Tax Expense (Benefit) -2.09M USD -590%
Net Income (Loss) Attributable to Parent -559M USD +12%
Earnings Per Share, Basic -6.39 USD/shares +28.8%
Earnings Per Share, Diluted -6.39 USD/shares +28.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 151M USD +108%
Accounts Receivable, after Allowance for Credit Loss, Current 93.3M USD +17.7%
Inventory, Net 43.3M USD +36.3%
Other Assets, Current 41.4M USD
Assets, Current 800M USD +33.4%
Property, Plant and Equipment, Net 272M USD -8.21%
Operating Lease, Right-of-Use Asset 23.9M USD -8.08%
Intangible Assets, Net (Excluding Goodwill) 165M USD +4.86%
Goodwill 44.4M USD 0%
Other Assets, Noncurrent 53.9M USD +93.1%
Assets 1.54B USD +24.2%
Accounts Payable, Current 36M USD +7.89%
Employee-related Liabilities, Current 82.9M USD +8.68%
Accrued Liabilities, Current 185M USD +3.59%
Contract with Customer, Liability, Current 4.44M USD +13.4%
Liabilities, Current 285M USD +12.2%
Deferred Income Tax Liabilities, Net 30.1M USD -5.08%
Operating Lease, Liability, Noncurrent 30.6M USD +54.3%
Other Liabilities, Noncurrent 16.1M USD +57.6%
Liabilities 1.18B USD -1.81%
Accumulated Other Comprehensive Income (Loss), Net of Tax 896K USD
Retained Earnings (Accumulated Deficit) -3.82B USD -17.1%
Stockholders' Equity Attributable to Parent 347M USD +994%
Liabilities and Equity 1.54B USD +24.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -191M USD -21.6%
Net Cash Provided by (Used in) Financing Activities -722K USD -145%
Net Cash Provided by (Used in) Investing Activities 94.4M USD -15.2%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 72.2M shares +2.99%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -97M USD -111%
Deferred Tax Assets, Valuation Allowance 1.04B USD +15.8%
Deferred Tax Assets, Gross 1.04B USD +15.7%
Operating Lease, Liability 43.2M USD +37.4%
Payments to Acquire Property, Plant, and Equipment 3.21M USD -87.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -556M USD +11.4%
Lessee, Operating Lease, Liability, to be Paid 54.4M USD +55.6%
Property, Plant and Equipment, Gross 374M USD +15.7%
Operating Lease, Liability, Current 12.6M USD +8.62%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11.9M USD +4.92%
Lessee, Operating Lease, Liability, to be Paid, Year One 16.2M USD +22.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +44.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.2M USD +218%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.43M USD +29.1%
Deferred Tax Assets, Operating Loss Carryforwards 266M USD +14.8%
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 80M USD +19.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.87M USD +97.9%
Additional Paid in Capital 4.17B USD +26.4%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 8.85M USD +68.9%
Deferred Tax Assets, Net of Valuation Allowance 5.96M USD -3%
Share-based Payment Arrangement, Expense 152M USD +15.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares